$AMST
Amesite Inc. Stock $amst

$amst Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000121390023012931 Filed on February 17, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$204.6K	$237.1K	$189.2K
YoY Change	-2.35%	25.36%	71.97%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$870.7K	$518.0K	$2.517M
YoY Change	-64.05%	-79.42%	5.31%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$163.3K	$175.3K	$222.4K
YoY Change	-32.02%	-21.18%	23.56%
% of Gross Profit
Operating Expenses	$1.150M	$949.1K	$2.517M
YoY Change	-52.51%	-62.29%	5.31%
Operating Profit	-$945.5K	-$712.0K	-$2.328M
YoY Change	-57.26%	-69.41%
Interest Expense	$17.48K	$12.51K	$5.610K
YoY Change	-555.21%	122.99%
% of Operating Profit
Other Income/Expense, Net	$816.00
YoY Change
Pretax Income	-$928.0K	-$699.5K	-$2.322M
YoY Change	-58.12%	-69.88%	1.41%
Income Tax
% Of Pretax Income
Net Earnings	-$928.0K	-$699.5K	-$2.322M
YoY Change	-58.12%	-69.88%	1.41%
Net Earnings / Revenue	-453.59%	-294.97%	-1227.59%
Basic Earnings Per Share	-$0.37	-$0.02	-$0.11
Diluted Earnings Per Share	-$0.37	-$0.02	-$105.6K
COMMON SHARES
Basic Shares Outstanding	30.40M shares	30.30M shares	21.98M shares
Diluted Shares Outstanding		30.31M shares	21.98M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.129M	$6.991M	$7.751M
YoY Change	-31.18%	-9.8%	-43.38%
Cash & Equivalents	$6.129M	$6.991M	$7.751M
Short-Term Investments
Other Short-Term Assets	$174.0K	$261.2K	$777.6K
YoY Change	-69.19%	-66.4%	-30.58%
Inventory
Prepaid Expenses
Receivables	$43.75K	$105.0K	$16.60K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.346M	$7.357M	$8.545M
YoY Change	-33.06%	-13.9%	-42.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$73.73K	$77.38K	$91.67K
YoY Change	-19.11%	-15.59%	14.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$922.0K	$969.6K	$1.439M
YoY Change	-28.81%	-32.61%	0.61%
TOTAL ASSETS
Total Short-Term Assets	$6.346M	$7.357M	$8.545M
Total Long-Term Assets	$922.0K	$969.6K	$1.439M
Total Assets	$7.268M	$8.327M	$9.984M
YoY Change	-32.55%	-16.59%	-38.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$94.49K	$112.9K	$236.3K
YoY Change	-77.12%	-52.24%	237.6%
Accrued Expenses	$110.7K	$58.19K	$125.8K
YoY Change	-46.45%	-53.73%	-21.4%
Deferred Revenue	$106.0K	$276.7K	$392.6K
YoY Change	-51.65%	-29.51%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$311.2K	$447.8K	$754.7K
YoY Change	-62.9%	-40.66%	-22.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$311.2K	$447.8K	$754.7K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$311.2K	$447.8K	$754.7K
YoY Change	-62.9%	-40.66%	-22.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.48M	-$31.55M
YoY Change
Common Stock	$255.00	$3.034K	$18.22K
YoY Change		-83.35%	-93.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.957M	$7.879M	$9.229M
YoY Change
Total Liabilities & Shareholders Equity	$7.268M	$8.327M	$9.984M
YoY Change	-32.55%	-16.59%	-38.56%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$928.0K	-$699.5K	-$2.322M
YoY Change	-58.12%	-69.88%	1.41%
Depreciation, Depletion And Amortization	$163.3K	$175.3K	$222.4K
YoY Change	-32.02%	-21.18%	23.56%
Cash From Operating Activities	-$746.9K	-$1.027M	-$2.604M
YoY Change	-41.46%	-60.56%	6.7%
INVESTING ACTIVITIES
Capital Expenditures	$115.7K	$65.67K	-$236.3K
YoY Change	-246.52%	-127.79%	2.73%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$115.7K	-$65.67K	-$236.3K
YoY Change	46.52%	-72.21%	2.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	0.000
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-746.9K	-1.027M	-2.604M
Cash From Investing Activities	-115.7K	-65.67K	-236.3K
Cash From Financing Activities	0.000	0.000	0.000
Net Change In Cash	-862.6K	-1.092M	-2.840M
YoY Change	-174.71%	-61.53%	6.36%
FREE CASH FLOW
Cash From Operating Activities	-$746.9K	-$1.027M	-$2.604M
Capital Expenditures	$115.7K	$65.67K	-$236.3K
Free Cash Flow	-$862.6K	-$1.092M	-$2.367M
YoY Change	-27.93%	-53.85%	7.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21743986	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39553
	dei	Entity Registrant Name EntityRegistrantName	AMESITE INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3431718
	dei	Entity Address Address Line1 EntityAddressAddressLine1	607 Shelby Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700 PMB 214
	dei	Entity Address City Or Town EntityAddressCityOrTown	Detroit
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48226
	dei	City Area Code CityAreaCode	(734)
	dei	Local Phone Number LocalPhoneNumber	876-8130
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
	dei	Trading Symbol TradingSymbol	AMST
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30400305	shares
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6991236	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7155367	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	104985	usd
CY2022Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	14545	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	261223	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	560084	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7357444	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	7729996	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77377	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	87190	usd
CY2022Q4	amst	Capitalized Software Net CapitalizedSoftwareNet	892217	usd
CY2022Q2	amst	Capitalized Software Net CapitalizedSoftwareNet	1066674	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	969594	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1153864	usd
CY2022Q4	us-gaap	Assets Assets	8327038	usd
CY2022Q2	us-gaap	Assets Assets	8883860	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	112863	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	122285	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	36200	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	174056	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	276740	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	342672	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	21985	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	109095	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	447788	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	748108	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30344305	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30344305	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25993484	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25993484	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3034	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2559	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39430054	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	37410209	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31553838	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29277016	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7879250	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8135752	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8327038	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8883860	usd
CY2022Q4	us-gaap	Revenues Revenues	237139	usd
CY2021Q4	us-gaap	Revenues Revenues	189174	usd
	us-gaap	Revenues Revenues	517421	usd
	us-gaap	Revenues Revenues	329865	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	316348	usd
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1451979	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1292668	usd
CY2022Q4	amst	Technology And Content Development TechnologyAndContentDevelopment	431087	usd
CY2021Q4	amst	Technology And Content Development TechnologyAndContentDevelopment	681018	usd
	amst	Technology And Content Development TechnologyAndContentDevelopment	912274	usd
	amst	Technology And Content Development TechnologyAndContentDevelopment	1477126	usd
CY2022Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	201696	usd
CY2021Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	384027	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	606728	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	871260	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	949131	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	2517024	usd
	us-gaap	Operating Expenses OperatingExpenses	2811670	usd
	us-gaap	Operating Expenses OperatingExpenses	5036134	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-711992	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2327850	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2294249	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4706269	usd
CY2022Q4	us-gaap	Other Noncash Income OtherNoncashIncome	12508	usd
CY2021Q4	us-gaap	Other Noncash Income OtherNoncashIncome	7273	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	17959	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	7535	usd
CY2022Q4	us-gaap	Other Noncash Expense OtherNoncashExpense	0	usd
CY2021Q4	us-gaap	Other Noncash Expense OtherNoncashExpense	1662	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	531	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	1662	usd
CY2022Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	12508	usd
CY2021Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5611	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	17428	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5873	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-699484	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-2322239	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2276821	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4700396	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21984947	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28862964	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21743986	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	11735090	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2378157	usd
CY2021Q3	amst	Net Of Offering Costs NetOfOfferingCosts	140000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1360000	usd
CY2021Q3	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	389085	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	11106018	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8135752	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1577338	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	61250	usd
CY2022Q3	amst	Net Of Offering Costs NetOfOfferingCosts	142500	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1850501	usd
CY2022Q3	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	175779	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	8645944	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-699484	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10690	usd
CY2022Q4	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	-77900	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7879250	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2276821	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4700396	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	362340	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	441849	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	97879	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	811611	usd
	amst	Value Of Common Stock Issued In Exchange For Consulting Services ValueOfCommonStockIssuedInExchangeForConsultingServices	71940	usd
	amst	Value Of Common Stock Issued In Exchange For Consulting Services ValueOfCommonStockIssuedInExchangeForConsultingServices	22698	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-90440	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	34525	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-298860	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	478160	usd
	amst	Acquisition Of Capitalized Software Included In Accounts Payable AcquisitionOfCapitalizedSoftwareIncludedInAccountsPayable	-9422	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2687748	usd
	amst	Acquisition Of Capitalized Software Included In Accounts Payable AcquisitionOfCapitalizedSoftwareIncludedInAccountsPayable	138615	usd
	amst	Accrued Compensation AccruedCompensation	-137856	usd
	amst	Accrued Compensation AccruedCompensation	-129398	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-65932	usd
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30305566	shares
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	59368	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-87110	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-13631	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1836562	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3812919	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2861	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8804	usd
	us-gaap	Payments For Software PaymentsForSoftware	175209	usd
	us-gaap	Payments For Software PaymentsForSoftware	500624	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-178070	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	517000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-509428	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1850501	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1360000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1850501	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1360000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-164131	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2962347	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7155367	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10713091	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6991236	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7750744	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1 - Nature of Business and Liquidity</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amesite Inc. (the “Company”) was incorporated in November 2017. The Company is an artificial intelligence driven platform and course designer, that provides customized, high performance and scalable online products for schools and businesses. The Company uses machine learning to provide a novel, mass customized experience to learners. The Company’s customers are businesses, universities and colleges, and K-12 schools. The Company’s activities are subject to significant risks and uncertainties. The Company’s operations are considered to be in one segment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 18, 2020, we consummated a reorganizational merger, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), dated July 14, 2020 (“Effective Date”), whereby we merged with and into Amesite Inc. (“Amesite Parent”) our former parent corporation, with our Company resulting as the surviving entity. In connection with the same, we filed a Certificate of Ownership and Merger with the Secretary of State of the State of Delaware, and changed our name from “Amesite Operating Company” to “Amesite Inc.” The stockholders of Amesite Parent approved the Merger Agreement on August 4, 2020. The directors and officers of Amesite Parent became our directors and officers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Pursuant to the Merger Agreement, on the Effective Date, each share of the Amesite parent’s common stock, $0.0001 par value per share, issued and outstanding immediately before the Effective Date, was converted, on a one-for-one basis, into shares of our common stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, each option or warrant to acquire shares of Amesite Parent outstanding immediately before the Effective Date was converted into and became an equivalent option to acquire shares of our common stock, upon the same terms and conditions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Going Concern</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying condensed financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The Company is developing its customer base and has not completed its efforts to establish a stabilized source of revenue sufficient to cover its expenses. The Company has had a history of net losses and negative cash flows from operating activities since inception and expects to continue to incur net losses and use cash in its operations in the foreseeable future.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>In addition, the Company has received a notice from the Nasdaq related to their failure to maintain a minimum bid price of $1 per share. The Company is not currently in compliance with the Nasdaq listing rules and if the Company does not regain compliance by March 6, 2023, the common stock of the Company will become subject to delisting. If the Company’s common stock is delisted, it may affect the Company’s ability to obtain financing, trade or sell shares of their common stock, and/or forecasted operations could be negatively impacted in an amount that the Company cannot currently quantify.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assessment of the Company’s ability to meet its future obligations is inherently judgmental, subjective and susceptible to change. <span>Based on their current forecast, management believes that it will have sufficient cash and cash equivalents to maintain the Company’s planned operations for the next twelve months following the issuance of these financial statements; however, there is uncertainty in the forecast and therefore the Company cannot assert that it is probable. The Company has considered both quantitative and qualitative factors that are known or reasonably knowable as of the date of these financial statements are issued and concluded that there are conditions present in the aggregate that raise substantial doubt about the Company’s ability to continue as a going concern. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>In response to the conditions, management plans include generating cash by completing financing transactions, which may include offerings of common stock. However, these plans are subject to market conditions, and are not within the Company’s control, and therefore, cannot be deemed probable. There is no assurance that the Company will be successful in implementing their plans. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The condensed financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</p>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i> </i></b></p>
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	250000	usd
CY2021Q4	us-gaap	Deferred Revenue Leases Net DeferredRevenueLeasesNet	1762000	usd
	amst	Leasehold Improvement LeaseholdImprovement	Shorter of estimated lease term or 10 years
	amst	Furniture And Fixturesin FurnitureAndFixturesin	P7Y
	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	350000	usd
	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	424000	usd
CY2022Q4	us-gaap	Deferred Revenue Leases Net DeferredRevenueLeasesNet	2533000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	330000	usd
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	77000	usd
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	14000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.70	pure
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.20	pure
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	342672	usd
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	333200	usd
	amst	Billings Billings	451490	usd
	amst	Billings Billings	389306	usd
	amst	Less Revenue Recognized From Continuing Operations LessRevenueRecognizedFromContinuingOperations	-517422	usd
	amst	Less Revenue Recognized From Continuing Operations LessRevenueRecognizedFromContinuingOperations	-329938	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	276740	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	392568	usd
	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	207000	usd
	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	164000	usd
CY2022Q4	amst	Potentially Dilutives PotentiallyDilutives	4710262	shares
CY2022Q2	amst	Potentially Dilutives PotentiallyDilutives	4922007	shares
	amst	Stock Warrants Issued StockWarrantsIssued	P5Y
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	600000	usd
CY2022Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	56500	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	811611	usd
CY2021Q3	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	172702	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>Risks and Uncertainties </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company operates in an industry subject to rapid change. The Company’s operations will be subject to significant risk and uncertainties including financial, operational, technological, and other risks associated with an early-stage company, including the potential risk of business failure.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On March 11, 2020, the World Health Organization declared the outbreak of a respiratory disease caused by a novel coronavirus as a “pandemic.” First identified in late 2019 and known now as COVID-19, the outbreak has impacted thousands of individuals worldwide. In response, many countries, including the United States, have implemented measures to combat the outbreak which have impacted global business operations. While management believes the Company’s operations have not been significantly impacted, the Company continues to monitor the situation. In addition, while the Company’s results of operations, cash flows and financial condition could be negatively impacted, the extent of the impact cannot be reasonably estimated at this time.</p>
	amst	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrants	4600000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P9Y11M19D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.022	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0012	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9298	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.463	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3163190	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.89
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M2D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.25
	amst	Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Remaining Contractual Termin Years Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageRemainingContractualTerminYearsGranted	P9Y10M20D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	47667	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.84
	amst	Share Based Compensation Arrangement By Share Based Payments Award Weighted Average Remaining Contractual Termin Years Terminated ShareBasedCompensationArrangementByShareBasedPaymentsAwardWeightedAverageRemainingContractualTerminYearsTerminated	P8Y6M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3119523	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.88
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P6Y9M25D
	amst	Weightedaverage Grantdate Fair Value Of Options Granted WeightedaverageGrantdateFairValueOfOptionsGranted	1000
	amst	Options Were Terminated OptionsWereTerminated	4	shares
CY2022Q4	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	15600	usd
CY2021Q4	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	422526	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	191379	usd
CY2021Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	337078	shares
	amst	Expected Termin Years ExpectedTerminYears	P5Y
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	156175	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-150000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	305500	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	226000	usd
	amst	Unrecognized Compensation Expense UnrecognizedCompensationExpense	1464000	usd
	amst	Warrants Disclosure WarrantsDisclosure	As of December 31, 2022 and June 30, 2022, there were 1,590,739 and 1,421,739 warrants outstanding, respectively. During the six months ended December 31, 2022 and 2021, the Company issued $169,000 and 63,489 common stock warrants, respectively, to a placement agent related to fundraisings and other advisory services. The warrants are fully vested, have a term of 5 years from closing date of the private placements and an exercise price of $1.00 per share (2022 warrants) and $6.00 per share (2021 warrants)
CY2021Q3	amst	Outstandings Outstandings	1234239	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1421739	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	169000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1590739	shares
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	63489	usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	23500	usd
CY2022Q4	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	0.9298	pure
CY2021Q4	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	0.45	pure
	amst	Riskfree Ratepercent RiskfreeRatepercent	0.038	pure
	amst	Riskfree Ratepercent RiskfreeRatepercent	0.0014	pure
	amst	Expected Termin Years ExpectedTerminYears	P9Y11M19D
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Entity Central Index Key EntityCentralIndexKey	0001807166
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	31500000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	17000	usd
CY2020Q2	amst	Investment Owned Balances Principal Amount InvestmentOwnedBalancesPrincipalAmount	2182500	usd
CY2022Q4	us-gaap	Derivative Cap Interest Rate DerivativeCapInterestRate	0.08	pure
	amst	Matured Matured	P1Y
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	2
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.75	pure
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	261900	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21984947	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28862964	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30305566	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30

Files In Submission

Name	View Source	Status
amst-20221231_cal.xml	Edgar Link	unprocessable
0001213900-23-012931-index-headers.html	Edgar Link	pending
0001213900-23-012931-index.html	Edgar Link	pending
0001213900-23-012931.txt	Edgar Link	pending
0001213900-23-012931-xbrl.zip	Edgar Link	pending
amst-20221231.xsd	Edgar Link	pending
f10q1222ex31-1_amesiteinc.htm	Edgar Link	pending
f10q1222ex31-2_amesiteinc.htm	Edgar Link	pending
f10q1222ex32-1_amesiteinc.htm	Edgar Link	pending
f10q1222ex32-2_amesiteinc.htm	Edgar Link	pending
f10q1222_amesiteinc.htm	Edgar Link	pending
amst-20221231_def.xml	Edgar Link	unprocessable
amst-20221231_pre.xml	Edgar Link	unprocessable
amst-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q1222_amesiteinc_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMST
Amesite Inc. Stock $amst

2023 Q1 Form 10-Q Financial Statement

#000121390023012931 Filed on February 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMST Amesite Inc. Stock $amst

2023 Q1 Form 10-Q Financial Statement

#000121390023012931 Filed on February 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMST
Amesite Inc. Stock $amst